Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Teleios Health vs TRYM Health

Teleios Health
Graded #327

Lower grade

vs+13.599999999999994
TRYM Health
Graded #67

Higher grade

The verdict

TRYM Health takes it — 73.8/100 to 60.2/100.

TRYM Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTRYM Health +12
84
96
Dose & formulationTRYM Health +8
64
72
Clinical oversightTRYM Health +22
49
71
Labs & monitoringTRYM Health +5
48
53
FulfillmentTRYM Health +32
42
74
Contract termsEven
55
55
Teleios Health · left barTRYM Health · right bar

The numbers

MetricTeleios HealthTRYM Health
WeighScore60.2/10073.8/100
GradeCC
Scorecard rank#327#67
Semaglutide$99/mo (starting dose, compounded)$96/mo (all doses, compounded)
Tirzepatide$139/mo (starting dose, compounded)$126/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Teleios Health

Graded #327 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
TRYM Health

Graded #67 · C

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

Where it loses points

  • Compounding pharmacy partner not named
  • Not LegitScript-certified (no certification displayed)
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard